Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic Rhinitis

NCT00152412 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis

Interventions

DRUG: Levocetirizine oral solution

Sponsor

UCB Pharma